Literature DB >> 6100804

Adoptive T cell immunotherapy of MSV-induced tumours in nude mice. Part II. Sequential analysis of serum immune complexes and blocking activity in reconstituted mice in relation to tumour biology.

D F Tucker, R A Knight, P H Warne.   

Abstract

In seven separate experiments, nude (nu/nu) mice carrying established murine sarcoma virus (MSV) tumours were reconstituted with syngeneic (+/+) immune splenic T cells. These immune protected mice were randomly divided to provide smaller groups for serial exsanguination. At various time points mice were individually bled and CIC concentration and blocking activity of each individual serum was determined. Control sera were obtained from nu/nu and adult +/+ mice inoculated with tumour cells only, and from nu/nu mice protected with normal +/+ spleen cells. In all the mice studied, CIC and blocking appeared to be mutually independent parameters throughout the MSV tumour course. On the other hand, in immune protected mice considered alone or together with the control groups, CIC and time after tumour cell inoculation, but not tumour size, were significantly correlated. A significant relationship between blocking and tumour size was also established, although this only applied to immune protected mice. However, analysis of the combined data from sequentially bled immune protected mice in relation to different phases of tumour behaviour, did not support the notion that blocking, and more particularly the persistence of CIC, contribute to tumour regrowth and dissemination.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6100804     DOI: 10.1007/bf00736410

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  27 in total

1.  Nonspecific and specific immunosuppression in tumour-bearing mice by soluble immune complexes.

Authors:  R M Gorczynski; D G Kilburn; R A Knight; C Norbury; D C Parker; J B Smith
Journal:  Nature       Date:  1975-03-13       Impact factor: 49.962

2.  Immunization with p30 enhances the growth of a rat Moloney sarcoma.

Authors:  J M Jones; S J Kennel; J D Feldman
Journal:  J Immunol       Date:  1977-01       Impact factor: 5.422

3.  Recognition of marrow elements by natural killer cells: are NK cells involved in haemopoietic regulation?

Authors:  T K O'Brien; J A Kendra; H A Stephens; R A Knight; A J Barrett
Journal:  Br J Haematol       Date:  1983-01       Impact factor: 6.998

4.  Circulating immune complexes in Lyme arthritis. Detection by the 125I-C1q binding, C1q solid phase, and Raji cell assays.

Authors:  J A Hardin; L C Walker; A C Steere; T C Trumble; K S Tung; R C Williams; S Ruddy; S E Malawista
Journal:  J Clin Invest       Date:  1979-03       Impact factor: 14.808

5.  The specificity of effector T cells activated by tumours induced by murine oncornaviruses.

Authors:  G R Shellam; R A Knight; N A Mitchison; R M Gorczynski; A Maoz
Journal:  Transplant Rev       Date:  1976

6.  Anti-tumor immunity in B-lymphocyte-deprived mice. III. Immunity to primary Moloney sarcoma virus-induced tumors.

Authors:  J Gordon; H T Holden; S Segal; M Feldman
Journal:  Int J Cancer       Date:  1982-03-15       Impact factor: 7.396

7.  Consistent fluctuations in quantities of circulating immune complexes during progressive and regressive phases of tumor growth.

Authors:  J C Jennette
Journal:  Am J Pathol       Date:  1980-08       Impact factor: 4.307

Review 8.  The murine sarcoma virus (MSV).

Authors:  J J Harvey; J East
Journal:  Int Rev Exp Pathol       Date:  1971

9.  Environmental and genetic factors determine the level of NK activity of nude mice and affect their suitability as models for experimental metastasis.

Authors:  N Hanna; T W Davis; I J Fidler
Journal:  Int J Cancer       Date:  1982-09-15       Impact factor: 7.396

10.  Cell-mediated immune reaction against tumors induced by oncornaviruses. II. Nature of the effector cells in tumor-cell cytolysis.

Authors:  J C Leclerc; E Gomard; F Plata; J P Levy
Journal:  Int J Cancer       Date:  1973-03-15       Impact factor: 7.396

View more
  2 in total

1.  Immunomodulatory effect of cyclophosphamide on host humoral immunity in Dunning's R-3327 adenocarcinoma of the prostate.

Authors:  R Bhatti; P Ray; N Bell
Journal:  Urol Res       Date:  1991

2.  Adoptive T cell immunotherapy of MSV-induced tumours in nude mice. Part I. Biology of tumour regression and recurrence.

Authors:  D F Tucker; R A Knight; P H Warne
Journal:  Clin Exp Metastasis       Date:  1983 Jul-Sep       Impact factor: 5.150

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.